The system is not broken, it was deliberately built this way
COVID-19 is our moment in history. It's time to reimagine the unjust system that was deliberately built to entrench big pharma's monopoly power.
Intellectual property: Removing IP Barriers
-
-
Monopolies causing “artificial rationing” in COVID-19 crisis as 3 biggest global vaccine giants sit on sidelines
The supply of safe and effective vaccines for all is being artificially rationed because of the protection of exclusive rights and monopolies of pharmaceutical corporations.
-
Who will get Pfizer’s COVID-19 vaccine?
A vaccine must reach the most vulnerable in each and every country and around the same time. Who gets the vaccine first must be based on need – not purchasing power. We demand affordable prices and fair allocation.
-
Ukraine’s reformed patent law comes into effect due to advocacy work
Dolutegravir (DTG) is widely available in Ukraine due to advocacy work. It provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access to life-saving treatment in the country.
-
NEW DATA: Treat 95% of people living with HIV for just FOUR WEEKS of global HIV drug sales.
The Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
-
A day in the life of a treatment activist
Make Medicines Affordable’s campaign manager, Sergey Kondratyuk talks about what being a treatment activist means to him.
-
THE PROBLEM WITH PATENTS | Commitments to HIV and universal health coverage are being undermined in middle-income countries
A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...
-
Unitaid investment expands our work on access to medicines
ITPC is delighted to be named one of three successful grantees of a new three year investment from Unitaid to...
-
Global Summit Refocuses the Fight for Access to Medicines
On 15-17 January 2018, over 120 community activists, civil society representatives, government officials, and key stakeholders representing 34 countries gathered...
-
High-, Middle- or Low-Income: Pharma Greed is Not Justified in Any Country!
On Wednesday, October 4, 2017 ITPC Intellectual Property and Access to Medicines Lead Othoman Mellouk addressed the Human Rights Council’s...
